Kitov Pharma’s arthritis drug meets main goal in late-stage study

Israel-based Kitov Pharmaceuticals Holdings Ltd said on Tuesday its lead drug met the primary efficacy endpoint of the trial protocol as approved by the U.S. Food & Drug Administration (FDA), reducing More...